2-(5-Methyl-6-oxo-1,6-dihydropyridazin-3-yl)acetic acid

Catalog No.: 
ACXKCU987
CAS No.: 
1922898-82-5
Molecular Formula: 
C6H6N2O3
Molecular Weight: 
168.15
2-(5-Methyl-6-oxo-1,6-dihydropyridazin-3-yl)acetic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$376.00In stockInquiry
250mg95%$600.00In stockInquiry
500mg95%$1000.00In stockInquiry
1g95%$1499.00In stockInquiry
5g95%$4496.00InquiryInquiry
10g95%$7494.00InquiryInquiry
25g95%$14987.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(5-Methyl-6-oxo-1,6-dihydropyridazin-3-yl)acetic acid
IUPAC Name2-(5-methyl-6-oxo-1,6-dihydropyridazin-3-yl)acetic acid
MDL No.MFCD23106035
Molecular FormulaC6H6N2O3
Molecular Weight168.15
SMILESO=C(O)CC(C=C1)=NNC1=O
InChI KeyBOUCOHOJTKZQRY-UHFFFAOYSA-N
Synonym2-(5-methyl-6-oxo-1,6-dihydropyridazin-3-yl)acetic acid;3-Pyridazineacetic acid, 1,6-dihydro-5-methyl-6-oxo-
CAS No.1922898-82-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACXKCU987 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBTAY482 route compound structure diagram
    ACBTAY4821674399-54-2In Stock
  2. Then
  3. ACXKCU987 route product structure diagram
    ACXKCU9871922898-82-5In Stock
Inquiry

2. ACXKCU987 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXKCU987 route product structure diagram
    ACXKCU9871922898-82-5In Stock
Inquiry

3. ACXKCU987 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXKCU987 route product structure diagram
    ACXKCU9871922898-82-5In Stock
Inquiry

Comments (0)